These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Kayl AE, Meyers CA. Curr Opin Obstet Gynecol; 2006 Feb; 18(1):24-8. PubMed ID: 16493256 [Abstract] [Full Text] [Related]
27. Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian carcinoma: a phase II Gynecologic Oncology Group study. Berek JS, Markman M, Blessing JA, Kucera PR, Nelson BE, Anderson B, Hanjani P. Gynecol Oncol; 1999 Jul; 74(1):48-52. PubMed ID: 10385550 [Abstract] [Full Text] [Related]
28. [Experiences in the treatment of leukopenia due to cytostatic therapy of ovarian and breast neoplasms]. Limburg H, Müller K, Brachetti AK. Med Welt; 1977 Aug 19; 28(32-33):1304-7. PubMed ID: 562966 [No Abstract] [Full Text] [Related]
34. Managing women with ovarian cancer: the role of the nurse. Clarke L, Bailey C. Nurs Stand; 1999 Aug 19; 25(5):41-9; quiz 50. PubMed ID: 21133017 [Abstract] [Full Text] [Related]
38. Chemotherapy and the nurse. 3. Nursing care in anti-tumour drug therapy. Tiffany R. Nurs Mirror Midwives J; 1975 Apr 01; 142(14):70-2. PubMed ID: 1045329 [No Abstract] [Full Text] [Related]
39. [Hematologic side effects of cancer chemotherapy. General characteristics and principles of management]. Jedrzejczak WW. Pol Arch Med Wewn; 1984 Feb 01; 71(2):65-70. PubMed ID: 6429645 [No Abstract] [Full Text] [Related]
40. [Peripheral blood picture in women treated with cytostatic for malignant tumors of the ovary]. Czarkwiani L, Misiewicz L. Ginekol Pol; 1966 May 01; 37(5):525-9. PubMed ID: 5911706 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]